# Aktana

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aktana

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.aktana.com
- Total disclosed funding: $31M
- Latest round: Series C (Sep 26, 2018)
- Investors on record: 3

## About

Aktana, Inc. specializes in providing AI-driven solutions that enhance customer engagement strategies within the life sciences sector, focusing on healthcare provider interactions for improved omnichannel success.Founded in 2008 and headquartered in San Francisco, US, Aktana, Inc. develops AI solutions for the life sciences industry, enabling effective healthcare provider engagement. The company has undergone strategic developments to enhance its core offerings and operates globally. Derek Choy is the founder, while the leadership team includes CEO David Ehrlich and John Vitalie. Aktana has successfully completed six deals, raising a total of USD 30 mn in Series D funding on September 4, 2020, reflecting a current company valuation of USD 135.724 mn.Aktana provides AI-powered solutions specifically designed for omnichannel success in the life sciences industry, with a focus on healthcare provider engagement. Its core product, the Aktana Platform, serves as an AI engine for customer engagement strategies, complemented by offerings such as Strategy Orchestration, Automated Intelligence, and Amplified Engagement. These solutions are tailored to various segments, including brand teams, medical affairs, and MedTech companies, maximizing engagement through personalized AI insights. Aktana serves over 350 brands across leading global life sciences firms, with deployments in North America, Europe, and Asia.Aktana generates revenue through a B2B subscription model and managed services, allowing life sciences companies to effectively implement its AI solutions. Clients subscribe to various product suites tailored to their needs in healthcare provider engagement and data insights. While specific pricing details are not disclosed, the revenue model supports comprehensive solutions that enhance brand performance and medical education initiatives. Aktana's AI-driven recommendations and contextual intelligence capabilities are integral to their value proposition, ensuring competitiveness in an AI-centric market.Aktana plans to leverage the USD 30 mn raised in Series D funding to enhance its product offerings and expand its market presence. The company is currently developing new solutions aimed at further optimizing healthcare provider engagement, with anticipated launches in the upcoming year. Additionally, Aktana targets expansion into emerging markets in Asia and Europe by 2023, aiming to extend its footprint in international life sciences markets.

## Funding rounds

- Series C, Sep 26, 2018, $21M — Transformation Capital
- Series B, Jun 14, 2016, $9.7M — Safeguard Scientifics, Starfish Ventures

## Investors

- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series B
- Starfish Ventures (https://capitalatlas.ai/funds/starfish-ventures) — Series B
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series C